Snake poisoning case study in short brief based on real case

Reading File
Finding Sources
Searching the Web

real case study snake envenomation clinical presentation treatment antivenom

Searching PubMed

"snake envenomation" AND "case report" AND antivenom

Reading Article

PMID: 38379491

Finding Sources
Reading File
Reading File
Reading File
Here is a concise, real case-based clinical brief on snake envenomation, combining a published case report with textbook guidance:

Snake Envenomation - Case Study Brief

The Real Case (Published 2024, Egypt)

Patient: 56-year-old male agricultural worker Incident: Bitten on the left foot, suspected pit viper/viperid snake

Presentation

  • Transported to a local hospital; received 3 polyvalent antivenom vials + analgesics
  • Transferred to the Egyptian National Environmental and Clinical Toxicology Research Center 12 hours later
  • On arrival: two small puncture wounds, left foot pain, blistering, and edema

Day 2 - Deterioration

  • Developed gingival bleeding and hematuria - classic signs of venom-induced consumption coagulopathy (VICC)
  • Labs: PT >3 minutes, PC <2.5%, INR = 23.43 (critical, normal <1.2)
  • Urinalysis: >100 RBCs (microscopic hematuria)

Treatment Course

DayInterventionResponse
Days 1-316 packs plasma + 40 total antivenom vials (VACSERA polyvalent)Hemoglobin fell, platelets dropped, jaundice appeared
Day 3LDH = 520, reticulocytes 3.5%, PT >300s, INR still unmeasurableAntivenom-unresponsive coagulopathy
Day 4-5Plasmapheresis + corticosteroids addedMarked improvement in PT, PC, INR
Day 6DischargedFull clinical recovery

Key Lesson

This case demonstrates antivenom-refractory envenomation - when standard antivenom fails, plasmapheresis (to clear circulating venom-antibody complexes) combined with corticosteroids can be life-saving. Published in Wilderness & Environmental Medicine (2024) - PMID: 38379491.

Clinical Framework (Textbook Context)

Why Vipers Cause Coagulopathy

Crotaline/viper venom is a complex enzyme mixture that:
  • Activates and consumes fibrinogen and platelets
  • Causes hemolysis and fibrinolysis
  • Alters vascular permeability, leading to hypovolemia
  • Tintinalli's Emergency Medicine, p. 1400

Grading Envenomation Severity

GradeFeatures
Dry bite (~25% cases)Fang marks only, no systemic effects
MildLocal pain, swelling, minor lab changes
ModerateProgressive swelling, coagulopathy (elevated PT/INR, low fibrinogen)
SevereSystemic collapse, hemorrhage, neurotoxicity, organ failure

Mandatory Labs (from Tintinalli's)

  • CBC, INR/PT, aPTT, fibrinogen level
  • Serum electrolytes, BUN, creatinine
  • Creatine kinase, ECG (if >50 yrs), ABG if respiratory compromise

Antivenom Indications

Antivenom is given when there is progression of:
  1. Local injury (worsening swelling, ecchymosis, pain)
  2. Hematologic abnormalities (dropping fibrinogen, rising INR, thrombocytopenia)
  3. Systemic effects (unstable vitals, altered consciousness)
First-line antivenoms (USA): CroFab (Crotalidae Polyvalent Immune Fab) or Anavip - ROSEN's Emergency Medicine

Elapid vs. Viperid Bites

FeatureViperid (Viper/Pit Viper)Elapid (Cobra/Krait/Coral)
Main toxicityHemotoxic, cytotoxicNeurotoxic
Local tissueMarked swelling, necrosisMinimal swelling
OnsetRapid local effectsDelayed neurologic (15-30 min)
Key dangerCoagulopathy, organ failureRespiratory paralysis

Global Burden

  • ~2.5 million venomous snakebites/year worldwide; ~150,000 deaths
  • India has the highest snakebite mortality globally
  • Majority of victims are rural agricultural workers (as in this case)
  • ROSEN's Emergency Medicine, p. 808

Take-Home Points

  1. Always transfer early - 12-hour delay in this case nearly cost the patient his life
  2. Coagulopathy can be severe and rapid - INR of 23 is a hemorrhagic emergency
  3. Track antivenom response with serial PT, INR, fibrinogen every few hours
  4. Antivenom failure exists - plasmapheresis + steroids can rescue refractory cases
  5. Prophylactic premedication before antivenom (hydrocortisone + chlorpheniramine) reduces anaphylaxis risk
This is a shared conversation. Sign in to Orris to start your own chat.